Prot# SOV302: A Multicenter, Phase 3, Open-Label Study to Assess the Efficacy and Safety of 0.1 mmol/kg Omniscan? (Gadodiamide Injection) for Magnetic Resonance Angiography (MRA) of the Aorto-iliac Arteries

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/05 → 5/17/06

Funding

  • GE-Healthcare (SOV302)